SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002822
Filing Date
2024-01-08
Accepted
2024-01-08 12:08:07
Documents
11
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-20240108.htm   iXBRL 8-K 47519
2 EX-99.1 srpt-ex99_1.htm EX-99.1 73720
  Complete submission text file 0000950170-24-002822.txt   243773

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srpt-20240108.xsd EX-101.SCH 23882
5 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20240108_htm.xml XML 4527
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 24519128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)